Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone
Bengt Glimelius, Sebastian Stintzing, John L. Marshall, et al.
Cancer Treatment Reviews (2021) Vol. 98, pp. 102218-102218
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer
Amit Dey, Abhijit Mitra, Surajit Pathak, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 50
Use of chemotherapy to treat hepatocellular carcinoma
Ziqi Hou, Jie Liu, Zhaoxing Jin, et al.
BioScience Trends (2022) Vol. 16, Iss. 1, pp. 31-45
Open Access | Times Cited: 56
Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance
Linfu Chen, Rui Zhao, Zheyu Kang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 43-56
Closed Access | Times Cited: 23
Oral Saccharomyces cerevisiae-Guided Enzyme Prodrug Therapy Combined with Immunotherapy for the Treatment of Orthotopic Colorectal Cancer
You‐Teng Qin, Xinhua Liu, Jiaxin An, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23497-23507
Closed Access | Times Cited: 8
Radioimmunotherapy in colorectal cancer treatment: present and future
Jingyi Shi, Zhuang Sun, Zhaoya Gao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation
Lu Chen, Kangyue Sun, Wenjie Qin, et al.
Cancer Letters (2023) Vol. 576, pp. 216420-216420
Closed Access | Times Cited: 17
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
Valentina Russo, Eleonora Lallo, Armelle Munnia, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4012-4012
Open Access | Times Cited: 26
Multifunctional CaCO3@Cur@QTX125@HA nanoparticles for effectively inhibiting growth of colorectal cancer cells
Shengyun Hu, Kunkun Xia, Xiaobei Huang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology
Ioannis A. Voutsadakis
Cancer Treatment and Research Communications (2023) Vol. 36, pp. 100746-100746
Open Access | Times Cited: 12
Clinical Implementation of Rare and Novel DPYD Variants for Personalizing Fluoropyrimidine Treatment: Challenges and Opportunities
Elena De Mattia, Noemi Milan, Yehuda G. Assaraf, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 10, pp. 3742-3759
Open Access | Times Cited: 4
Endoplasmic reticulum stress-related prognosis signature characterizes the immune landscape and predicts the prognosis of colon adenocarcinoma
Lichao Cao, Hui Dai, Shangqing Wei, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Tumor tropic delivery of FU.FA@NSs using mesenchymal stem cells for synergistic chemo-photodynamic therapy of colorectal cancer
Mahsa Jahedi Moghaddam, Azadeh Meshkini
Colloids and Surfaces B Biointerfaces (2023) Vol. 226, pp. 113333-113333
Closed Access | Times Cited: 10
Epigenetics and environmental health
Min Zhang, Ting Hu, Tianyu Ma, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 571-596
Closed Access | Times Cited: 3
Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX
Barbora Puzderova, Petra Belvončíková, Katarina Grossmannova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11094-11094
Open Access | Times Cited: 8
Progress of research on molecular targeted therapies for colorectal cancer
Shilin Huang, Jiazhou Ye, Xing Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Signal mining and analysis of trifluridine/tipiracil adverse events based on real-world data from the FAERS database
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Shenqi Sanjie Granules induce Hmox1-mediated ferroptosis to inhibit colorectal cancer
Meng Chen, Shengli Ma, Wenbo Ji, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38021-e38021
Open Access | Times Cited: 2
Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer
Pedro Cruz-Nova, Alejandra Ancira-Cortez, Guillermina Ferro‐Flores, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 12
Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
Yue Zhou, Qing Zhang, Minjia Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
Xing He, Huanrong Lan, Ketao Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
Hufei Wang, Zhi Li, Yangbao Tao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer
Yea Bin Cho, Ji Woong Kim, Kyun Heo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113051-113051
Open Access | Times Cited: 10
ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction
Sirui Long, Jie Wang, Fanbin Weng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
The emerging era of personalized medicine in advanced colorectal cancer
Claudia Wing‐Kwan Wu, Madeleine Reid, Simon J. Leedham, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 8, pp. 1411-1425
Closed Access | Times Cited: 9
Dermatan Sulfate/Chitosan Nanoparticles Loaded with an Anti‐Inflammatory Peptide Increase the Response of Human Colorectal Cancer Cells to 5‐Fluorouracil
Agustín Blachman, Ariadna María Birocco, Sofía Curcio, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 11
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top